Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | Q9HBH1 | 1/20 | 0.44 | |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19608616 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL1042434 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL8563828 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL7777870 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL23879493 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL24667473 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL8563312 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL9750430 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL8558195 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL8561176 | 1.00 | CA2 (0.53) | CA2GRIK1GRIK2GPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240398825-A1 | MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF | NANJING DELOVA BIOTECH CO., LTD. (CN) | 2024-12-05 | — | — | US | claimed |
| US-5720946-A | SYNERGISTIC EFFECT; DANDRUFF; PREVENTION ITCHING | SHISEIDO COMPANY, LTD. (JP) | 1998-02-24 | — | — | US | claimed |
| US-20240398825-A1 | MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF | NANJING DELOVA BIOTECH CO., LTD. (CN) | 2024-12-05 | — | — | US | disclosed |
| CN-115868499-A | Compound agricultural insecticide containing bromofenoxaprop-p-fluorobenzene bisamide and application thereof | 中农立华生物科技股份有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-115715543-A | Compound agricultural bactericidal composition, preparation and application thereof | 中农立华生物科技股份有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-114916552-A | Compound agricultural bactericide containing penthiopyrad and application thereof | 中农立华生物科技股份有限公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-113973815-B | Mixed solvent mainly comprising C6-C18 alkyl dimethyl amide, and preparation method and application thereof | 祺农化工科技(上海)有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-113973815-A | Mixed solvent mainly comprising C6-C18 alkyl dimethyl amide, and preparation method and application thereof | 祺农化工科技(上海)有限公司 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240398825-A1 | MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF | MB, PTGES, OPRM1 | CA2 2029/4885GRIK1 2198/4885GRIK2 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.